Results

Total Results: 1,134 records

Showing results for "days".

401. Smoking-Pregnancy-Infants Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
     March 11, 2013 - based on behavior at a particular point in time or during a brief specified period (e.g., 24 hours, 7 days

402. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
     March 01, 2011 - (index ED visit: 7.2% vs. 5.6%); PCI (index ED visit: 5% vs. 3%; 28 days: 0.6% in both groups); CABG … (index ED visit: 1% in both groups; 28 days: 0% in both groups); and additional testing at the index … ED visit and through 28–30 days (28 days: SPECT [1.6% vs. 1.8%], stress echocardiography [0% in both … confidence interval [CI], 0 to 7 per 100 patients; I2 = 0%) and after the index visit through 28 days … There was high-strength evidence from one large trial that any revascularization within 90 days was

403. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
     October 01, 2014 - Mifepristone is FDA-approved for medical terminating pregnancy up to 49 days (branded as Mifeprex®) … Cushing’s disease.14 Mifepristone is also approved for the medical termination of pregnancy at up to 49 days … lessen the signs of depression.73 Clinical data suggest that these changes may be evident as soon as 3 days … depressive symptoms improved both significantly and rapidly and that these effects lasted from 3 days … This statistically significant superiority was maintained 7 days after administration.88 Several

404. Health-Careassociated-Infections Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_executive.pdf
     November 01, 2012 - 4,761 115 to 10,617 93 to 1,794 NA Postintervention infection rate 0 to 7.7 per 1,000 catheter- days … 0.7 to 22.5 per 1,000 ventilator-days 0% to 7.7% 1.8 to 12.9 per 1,000 catheter-days NA Baseline … infection rate 1.84 to 17 per 1,000 catheter- days 1.9 to 39.7 infections per 1,000 ventilator-days … 1.1% to 15% 1.7 to 21.5 per 1,000 catheter-days NA 8 Study Characteristic Category CLABSI

405. Introduction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
     February 01, 2009 - On that date, cohort members were required to have at least 365 days of continuous enrollment in TennCare

406. Evidence-Summary-CER-206-Sodium-And-Potassium-Intake-Effects-On-Chronic-Disease-Outcomes-And-Risk (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
     June 01, 2018 - Aburto and our current review; the Graudal review excluded only trials with a duration of less than 4 days

407. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to …

408. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
     January 01, 2024 - receiving definitive RT from 2004 to 2015 Nodal or metastatic disease; delayed treatment (ADT or RT >180 days … evidence of nodal (N0) or distant metastatic disease (M0), digital rectal exam and serum PSA within 180 days

409. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - 1 Comparative Effectiveness Review Number 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update Executive Summary Background Cardiovascular disease (CVD) includes conditions such as coronary heart disease, stroke, heart failure, arrhythmia, heart valve disease, congenital heart …

410. Research White Paper Managing Missing Data in Patient Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - Typically, the PRO must be completed within a protocol-specified window (e.g., 30 days). … consideration of a simple example: consider a longitudinal study which collects data at baseline, 30 days

411. CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
     October 11, 2019 - Thirty-day hospital admissions were chosen because hospital admissions within 30 days of an index hospitalization … At hospital discharge, patients generally require days or weeks of supportive care as they convalesce … publication found the highest risk of hospital readmission or death to occur within the first few days

412. Total Worker Health® (TWH) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
     April 01, 2016 - Total Worker Health® (TWH) 1 Comparative Effectiveness Review Number 175 Total Worker Health® Effective Health Care Program Executive Summary Background The American worksite has been a venue for both health protection and health promotion programs. Health protection programs are interventions aimed specifi…

413. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - Median length of hospital stay (1.2 vs. 2.7 days) and median length of catheterization (7 vs. 13 days … linked data from 2003-2007 Postoperative 30- day complications, Anastomotic strictures 31-365 days … Median length of hospital stay (1.2 vs. 2.7 days) and median length of catheterization (7 vs. 13 days

414. Asthma-Immunotherapy-2010 Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
     January 01, 2010 - Missed days of school/work Timing Studies with any duration of followup will be included. … symptoms (sneezing/nasal congestion/rhinorrhea/itchy nose/ocular symptoms/etc) b) QOL c) symptom-free days … d) Days with no use of rescue medicine (eg: antihistamine; decongestant) e) Visual analog score … Individual symptoms (wheezing/chest tightness/shortness of breath/cough) b) QOL c) Symptom-free days … d) Days with no use of rescue medicine (eg: albuterol) e) Visual analog score f) Asthma exacerbations

415. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
     October 01, 2016 - In all cases, patient discharges occur within 35 days of beginning treatment.34 Stays longer than 35 … days would indicate a chronic care setting. … within 24 hours) treatment with at least one dose of an antipsychotic medication led to fewer mean days … no delirium treatment, both in the first 24 hours, 3 vs. 6 days, p<0.00151 13 Key Question 2a: … For example, the Abderhalden trial44 implemented the risk assessment protocol for the first 3 days,

416. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - Median length of hospital stay (1.2 vs. 2.7 days) and median length of catheterization (7 vs. 13 days … linked data from 2003-2007 Postoperative 30- day complications, Anastomotic strictures 31-365 days … Median length of hospital stay (1.2 vs. 2.7 days) and median length of catheterization (7 vs. 13 days

417. Multidisciplinary Rehabilitation Programs for Moderate to Severe Traumatic Brain Injury in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation-future_research.pdf
     January 01, 2013 - programs in small groups of individuals that received several hours of treatments per day, several days … programs in small groups of individuals that received several hours of treatments per day, several days

418. Disposition of Comments Report for Interventions To Modify Health Care Provider Adherence to Asthma Guidelines (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_disposition-comments.pdf
     May 19, 2013 - TEP #3 Introduction Missed days of school and/or work, quality of life, and parental/patient perceptions … They are quite different than traditional clinical outcomes listed (symptom days, QOL, ER visits, lung … selected two components of asthma control as defined by the NAEEP Expert Panel Report 3, symptom days

419. Undescended-Testicle Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
     December 01, 2012 - times daily 4 weeks 9.0 8.0 Hagberg and Westphal, 1982 N = 50 4 weeks Poor 100 µg 3 times daily 28 days … 62.0 3.0 Karpe et al., 1983 N = 50 6 months Poor 100 µg 6 times daily 28 days 20.0 12.0 Wit et … al., 1986 N = 49 8 weeks Poor 400 µg 3 times daily 28 days 37 18 CI = confidence interval; LHRH

420. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
     December 14, 2012 - For logistic convenience, fresh tissue can be stored for up to 7 days in RNARetain and shipped at room … The turn-around time for the Oncotype DX® Colon Cancer assay is 10-12 days, with 1-2 days more for MMR